CX3CL1 expression increases in the heart and serum of patients with end-stage heart failure due to coronary artery disease or dilated cardiomyopathy [29], which involves however different mechanisms from the compensated hypertrophy due to arterial hypertension or aortic stenosis. The gene discussed is CX3CL1; the disease is dilated cardiomyopathy.